Literature DB >> 7970941

Increased activity of interleukin-6 but not tumor necrosis factor-alpha in lung lavage of premature infants is associated with the development of bronchopulmonary dysplasia.

A Bagchi1, R M Viscardi, V Taciak, J E Ensor, K A McCrea, J D Hasday.   

Abstract

Although considerable evidence suggests that bronchopulmonary dysplasia (BPD) is the result of prolonged inflammation and impaired healing of the immature lung, the mediators that regulate inflammation in neonatal lung injury have not been completely elucidated. We examined whether the cytokines IL-6 and tumor necrosis factor-alpha (TNF) interact to modulate a cascade of cell-cell signaling events involved in inflammation contributing to the development of BPD. To determine the relative activities of these cytokines in neonatal lung injury, lung lavage samples were serially obtained from 1 to 28 d from 11 infants with self-limited respiratory distress syndrome (RDS), 19 infants with evolving BPD, and 10 control infants ventilated for nonpulmonary reasons. On the first day of life, there were no differences in antigenic IL-6 concentrations in lavage fluids among the BPD, RDS, and control groups, but IL-6 activity determined by the 7TD1 proliferation assay was 15-fold and 6.6-fold higher in lung lavage of infants who developed BPD compared with activities in lavage from control and RDS infants, respectively (control, 49.4 +/- 17.6; RDS, 117.3 +/- 59.6; BPD, 779.5 +/- 212.6 x 10(3) hybridoma units/L, mean +/- SEM, p = 0.02). This suggests that pathways for inactivating or inhibiting IL-6 that may be present in the lungs of RDS and control infants may be deficient in BPD infants. IL-6 activity remained elevated in lavage of BPD infants for the first 2 wk and declined to low levels by d 28.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7970941     DOI: 10.1203/00006450-199408000-00017

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  24 in total

Review 1.  Lung growth: implications for the newborn infant.

Authors:  S Kotecha
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-01       Impact factor: 5.747

2.  Immature anti-inflammatory response in neonates.

Authors:  C Schultz; P Temming; P Bucsky; W Göpel; T Strunk; C Härtel
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

Review 3.  Frontiers in pulmonary hypertension in infants and children with bronchopulmonary dysplasia.

Authors:  Joseph M Collaco; Lewis H Romer; Bridget D Stuart; John D Coulson; Allen D Everett; Edward E Lawson; Joel I Brenner; Anna T Brown; Melanie K Nies; Priya Sekar; Lawrence M Nogee; Sharon A McGrath-Morrow
Journal:  Pediatr Pulmonol       Date:  2012-07-06

Review 4.  Effects of antenatal and postnatal corticosteroids on the preterm lung.

Authors:  J Vyas; S Kotecha
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-09       Impact factor: 5.747

5.  Soluble L-selectin concentration in bronchoalveolar lavage fluid obtained from infants who develop chronic lung disease of prematurity.

Authors:  S Kotecha; M Silverman; R J Shaw; N Klein
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-03       Impact factor: 5.747

6.  Early increase of TNF alpha and IL-6 in tracheobronchial aspirate fluid indicator of subsequent chronic lung disease in preterm infants.

Authors:  B Jónsson; K Tullus; A Brauner; Y Lu; G Noack
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-11       Impact factor: 5.747

7.  NF-kappaB in tracheal lavage fluid from intubated premature infants: association with inflammation, oxygen, and outcome.

Authors:  A Bourbia; M A Cruz; H J Rozycki
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-07-27       Impact factor: 5.747

8.  Does the use of 50% oxygen at birth in preterm infants reduce lung injury?

Authors:  A E Harling; M W Beresford; G S Vince; M Bates; C W Yoxall
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-04-29       Impact factor: 5.747

9.  Characterization of a murine model of Ureaplasma urealyticum pneumonia.

Authors:  Rose M Viscardi; Jennifer Kaplan; Judith C Lovchik; Ju Ren He; Lisa Hester; Srinivas Rao; Jeffrey D Hasday
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

Review 10.  Cytokines in chronic lung disease of prematurity.

Authors:  S Kotecha
Journal:  Eur J Pediatr       Date:  1996-08       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.